Drug class in one race
CEACAM5 drugs for Non-Small Cell Lung Cancer
3 tracked CEACAM5 drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the CEACAM5 page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.
1 Phase 1/21 Phase 11 preclinical / unstaged